IRE1α-targeting downregulates ABC transporters and overcomes drug resistance of colon cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IRE1α-targeting downregulates ABC transporters and overcomes drug resistance of colon cancer cells

Published:2020-04 Issue: Volume:476 Page:67-74
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Gao Qiang,Li Xiu-xiu,Xu Yi-ming,Zhang Jin-zhao,Rong Shi-di,Qin Yan-qing,Fang Jing

Funder

Science and Technology Commission of Shanghai Municipality

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference44 articles.

1. Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation;Yusuf;Curr. Cancer Drug Targets,2003

2. Targeting multidrug resistance in cancer;Szakacs;Nat. Rev. Drug Discov.,2006

3. Circumventing tumor resistance to chemotherapy by nanotechnology;Liang;Methods Mol. Biol.,2010

4. Overcoming ABC transporter-mediated multidrug resistance: molecular mechanisms and novel therapeutic drug strategies;Li;Drug Resist. Updates,2016

5. Cancer chemoresistance; biochemical and molecular aspects: a brief overview;Kachalaki;Eur. J. Pharmaceut. Sci.,2016

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance to 5-fluorouracil: The molecular mechanisms of development in colon cancer cells;European Journal of Pharmacology;2024-11

2. The role of endoplasmic reticulum stress on reducing recombinant protein production in mammalian cells;Biochemical Engineering Journal;2024-10

3. Subcellular Drug Distribution: Exploring Organelle-Specific Characteristics for Enhanced Therapeutic Efficacy;Pharmaceutics;2024-09-04

4. Microcystin-LR Regulates Interaction between Tumor Cells and Macrophages via the IRE1α/XBP1 Signaling Pathway to Promote the Progression of Colorectal Cancer;Cells;2024-08-27

5. XBP1s activates METTL3/METTL14 for ER-phagy and paclitaxel sensitivity regulation in breast cancer;Cancer Letters;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3